Filter News

Geron Corporation To Present At The BIO Investor Forum

Published: Oct 13, 2015

MENLO PARK, Calif., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the BIO Investor Forum in San Francisco at 8:30 a.m. Pacific Time on Wednesday, October 21.

A live webcast of the presentation will be available through the Investor Relations pages of Geron’s website and at http://www.veracast.com/webcasts/bio/investorforum2015/39202230749.cfm. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.

About Geron

Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.

CONTACT: Anna Krassowska, Ph.D. Investor and Media Relations 650-473-7765 investor@geron.com media@geron.com

Primary Logo


Help employers find you! Check out all the jobs and post your resume.

Back to news